spot_img
Friday, July 19, 2024
HomeNewsBristol Myers to buy RayzeBio for about $4.1 billion

Bristol Myers to buy RayzeBio for about $4.1 billion

-


Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage, near Agen, France March 29, 2018.

Regis Duvignau | REUTERS

Bristol Myers Squibb said on Tuesday it will acquire radiopharmaceutical firm RayzeBio for about $4.1 billion.

Bristol said it will pay $62.50 for each share of RayzeBio in cash, representing a premium of 104% to the stock’s last close.

RayzeBio shares were halted ahead of the deal announcement.

This story is developing. Please check back for updates.



Source link

Related articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Latest posts